Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Amifampridine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 37,072Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Catalyst Pharma Settles Firdapse Patent Dispute with Lupin
    Catalyst Pharma Settles Firdapse Patent Dispute with Lupin

    25 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/25/3138433/13009/en/Catalyst-Pharmaceuticals-Announces-Settlement-of-FIRDAPSE-amifampridine-Patent-Litigation-with-Lupin-Pharmaceuticals.html

    GLOBENEWSWIRE
    25 Aug 2025
    Share Share
    Catalyst Sub-Licensee DyDo Pharma Launches FIRDAPSE® In Japan
    Catalyst Sub-Licensee DyDo Pharma Launches FIRDAPSE® In Japan

    21 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/21/3012650/13009/en/Catalyst-Pharmaceuticals-Announces-Sub-Licensee-DyDo-Pharma-Launched-FIRDAPSE-in-Japan.html

    GLOBENEWSWIRE
    21 Jan 2025
    Share Share
    Catalyst's Teva settlement postpones arrival of Firdapse generic
    Catalyst's Teva settlement postpones arrival of Firdapse generic

    09 Jan 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/catalyst-settles-teva-help-stave-firdapse-generic-until-2035

    FIERCE PHARMA
    09 Jan 2025
    Share Share
    Catalyst’s Sub-Licensee DyDo Gets Approval for FIRDAPSE in Japan
    Catalyst’s Sub-Licensee DyDo Gets Approval for FIRDAPSE in Japan

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2951972/13009/en/Catalyst-Pharmaceuticals-Announces-Sub-Licensee-DyDo-Pharma-Received-Approval-to-Commercialize-FIRDAPSE-in-Japan.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Catalyst Gets Higher FIRDAPSE® Maximum Dose Approval From FDA
    Catalyst Gets Higher FIRDAPSE® Maximum Dose Approval From FDA

    31 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/30/2891040/13009/en/Catalyst-Pharmaceuticals-Receives-U-S-FDA-Approval-For-Increased-Maximum-Daily-Dose-For-FIRDAPSE.html

    GLOBENEWSWIRE
    31 May 2024
    Share Share
    Catalyst to Participate in the 2024 Cantor Virtual MDS
    Catalyst to Participate in the 2024 Cantor Virtual MDS

    27 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/27/2853130/13009/en/Catalyst-Pharmaceuticals-to-Participate-in-the-2024-Cantor-Virtual-Muscular-Dystrophy-Symposium.html

    GLOBENEWSWIRE
    27 Mar 2024
    Share Share